skip to Main Content
Get your free newsletter: Actionable insight each morning for self-directed investors. 
Home » UK Shares » AIM Risers and Fallers » AIM round-up: Ncondezi Energy, Mysale, Reabold Resources

London’s AIM market has made little progress during the session with concerns over Russia’s alleged retreat from the Ukrainian border weighing on sentiment and being further dragged down by a soft start on Wall Street. The index reached the bell less than two points higher at 1080.21.

  • Ncondezi Energy +70%
  • Mysale +48%
  • Reabold Resources +24%
  • RA international -28%
  • Advanced Oncotherapy -10%

Ncondezi Energy [LON:NCCL] was the day’s biggest gainer with shares adding 60% by the closing bell. The stock has been struggling to find support since questions were raised over China’s commitment to fossil fuel power plants, but news reports today have highlighted a change of stance from Beijing in light of spiralling gas prices. The subsequent read across appears to be driving renewed interest in the stock – at least for now.

Mysale [LON:MYSL] also had a good session, adding 48% by the bell and clawing back some of yesterday’s losses. The situation here does seem to simply be one of that bout of selling being overblown – whilst the situation wasn’t great, it was more about bad timing that anything being fundamentally wrong with the business.

A notable mention for Reabold Resources [LON:RBD] which also moved higher today, finding itself in second place up by 24% at the bell. The company’s shares have been finding favour off the back of rising gas prices and jumped again today, testing new highs for the year to date.

RA International [LON:RAI] was the day’s biggest faller, off 28% at 4.30pm. A trading update issued this morning evidently failed to impress with a deterioration in margins being particularly evident, whilst the company also noted ongoing delays connected to contract wins and tenders. The business outlines a proactive response, aiming to attract more government work in the future, and promises further updates in due course.

Shares in Advanced Oncotherapy [LON:AVO] also struggled today, with the company extending the run lower that has been in play since the start of the year. Another 11% was accrued on the downside today in unremarkable volumes. Could news be incoming here?

Related

This article is not investment advice. Investors should do their own research or consult a professional advisor.

Tony Cross

Tony Cross

Tony Cross is a market commentator with over 15 years of experience, producing compelling, insightful copy for journalists and investors alike. Focusing on macroeconomics, UK blue chip equities and inter market analysis, Cross's commentary is well regarded for its clarity and ability to cut through the waffle. He has been quoted in publications as diverse as The Financial Times, The Times, The Guardian and The Sun. He has also been a regular guest on both Share Radio and TipTV.

Stocks in Focus

Here are some of the smaller companies we follow most closely. They represent significant growth stories in our view. Our in-depth reports detail why we like them.

Comments

Subscribe for more stories like this, 8am weekdays - for free!


Get your free daily newsletter: 

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

Pepperstone
FP Markets
IG
Spreadex
WisdomTree
ActivTrades
Back To Top